Merosure O ER 300 Tablet contains Faropenem 300mg, a broad-spectrum oral carbapenem antibiotic effective against a wide range of Gram-positive and Gram-negative bacterial infections. Faropenem exerts its bactericidal action by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis and death. Merosure O ER 300 is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other susceptible bacterial infections. The extended-release formulation ensures sustained plasma concentrations, enhancing therapeutic efficacy and improving patient compliance by reducing dosing frequency. It is important to use Merosure O ER 300 only under medical supervision, following appropriate culture and sensitivity testing to minimize the risk of resistance development. Common adverse effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, which are generally mild and transient. Caution is advised in patients with a history of hypersensitivity to beta-lactam antibiotics. Dose adjustment may be necessary in patients with renal impairment. Merosure O ER 300 should be stored in a cool, dry place, away from direct sunlight. Complete the prescribed course to prevent recurrence and resistance.